Medifast, Inc. (LON:0K05)
Market Cap | 97.26M |
Revenue (ttm) | 481.23M |
Net Income (ttm) | 1.67M |
Shares Out | n/a |
EPS (ttm) | 0.15 |
PE Ratio | 58.23 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 869 |
Average Volume | 262 |
Open | 12.13 |
Previous Close | 12.01 |
Day's Range | 12.13 - 12.28 |
52-Week Range | 12.13 - 109.46 |
Beta | 1.08 |
RSI | 36.20 |
Earnings Date | Apr 30, 2025 |
About Medifast
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and sou... [Read more]
Financial Performance
In 2024, Medifast's revenue was $602.46 million, a decrease of -43.80% compared to the previous year's $1.07 billion. Earnings were $2.09 million, a decrease of -97.90%.
Financial numbers in USD Financial StatementsNews

Medifast: GLP-1 Caused A Vicious MLM Flywheel Effect
Medifast, Inc.'s business is deteriorating as GLP-1 medication has lowered demand, causing a vicious flywheel effect as coaches are exiting the platform. The company is trying to reposition itself as ...

How Is The Market Feeling About Medifast?
Medifast's (NYSE: MED) short percent of float has risen 3.91% since its last report. The company recently reported that it has 1.39 million shares sold short , which is 19.38% of all regular shares t...
Medifast outlines 2025 priorities with plans for $15M-$20M cost savings and new product expansions
Medifast, Inc. (MED) Q4 2024 Earnings Call Transcript
Medifast Inc (MED) Q4 Earnings: EPS of $0.07 Beats Estimate, Revenue at $119M Surpasses Expectations
Medifast Inc (MED) Q4 Earnings: EPS of $0.07 Beats Estimate, Revenue at $119M Surpasses Expectations
Medifast, Inc. 2024 Q4 - Results - Earnings Call Presentation
Medifast Non-GAAP EPS of $0.10 beats by $0.26, revenue of $119M beats by $4.75M

Medifast Announces Fourth Quarter and Full Year 2024 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter...

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourt...

Medifast: Strong Balance Sheet, But I Lack Conviction In The Turnaround
Read here for a detailed financial analysis of Medifast stock post-pandemic, GLP-1 impact, and the company's collaboration with LifeMD.

Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE:MED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTAVIA, today announced OPTAVIA ASCEND — a new product l...
Medifast Inc (MED) Shares Down 3.64% on Dec 30
Medifast Inc (MED) Shares Down 3.64% on Dec 30
Medifast Inc (MED) Shares Drop Amid Market Volatility
Medifast Inc (MED) Shares Drop Amid Market Volatility

Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today shared findings from a recent independen...

Medifast: Earnings Surprise, New AI Technologies, And Extremely Undervalued
Medifast reported better-than-expected quarterly EPS and is investing in new marketing strategies, AI technologies, and supply chain optimization to drive future growth. Despite a decline in the numbe...

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript
Medifast, Inc. (NYSE:MED) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Steven Zenker - Vice President-Investor Relations Dan Chard - Chairman & Chief Executive Of...

Medifast Announces Third Quarter 2024 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the third quarter ...

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the third...

The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.
LOS ANGELES, CA / ACCESSWIRE / October 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ...

Medifast Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Invited To Reach Out To The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / October 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ...

The Schall Law Firm Urges Shareholders To Join An Inquiry Into Medifast, Inc. For Possible Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / October 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ...

Medifast Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, In...

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, In...

The Schall Law Firm Invites Shareholder Participation In A Securities Fraud Inquiry Into Medifast, Inc.
LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, In...

Medifast Inc Is Being Investigated For Violating Securities Laws And Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / September 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, In...